Mesenchymal stem cell insights: prospects in cardiovascular therapy

Area of Science:

• Regenerative Medicine
• Cardiology
• Stem Cell Biology

Background:

• Ischemic heart damage leads to remodeling and fibrosis, causing heart failure.
• Mesenchymal stem cells (MSCs) are multipotent and hypoimmunogenic, aiding tissue repair and immune tolerance.
• MSC therapy has demonstrated feasibility, safety, and efficiency in preclinical cardiac regeneration studies.

Purpose of the Study:

• To review experimental and clinical findings on Mesenchymal stem cells (MSCs) in cardiac repair.
• To highlight the roles of MSCs in cardiac tissue repair, transdifferentiation, and the myocardial niche.
• To discuss the therapeutic efficacy and current limitations of MSC-based cardiac therapies.

Main Methods:

• Review of recent experimental and clinical studies on Mesenchymal stem cells (MSCs) for cardiac therapy.
• Analysis of MSCs' roles in cardiac tissue repair, transdifferentiation, and niche optimization.
• Examination of the molecular mechanisms and therapeutic efficacy of MSCs in cardiovascular disorders.

Main Results:

• Mesenchymal stem cells (MSCs) show potential for treating ischemic and nonischemic cardiovascular disorders.
• Clinical trials (Phase I/II) have tested the efficacy of MSC therapy for heart diseases.
• Hypothesized mechanisms include cardiomyocyte regeneration, paracrine effects, niche optimization, and inflammatory control.

Conclusions:

• Mesenchymal stem cells (MSCs) represent a promising therapeutic tool for cardiovascular disorders.
• Further research is needed to clarify the precise molecular mechanisms underlying MSC efficacy in cardiac recovery.
• Addressing current bottlenecks is crucial for advancing MSC-based cardiac therapies.